TPA, a well-known tumor promoter, decreased the response of nuclear p5
3 immunoreactivity to benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE)-DNA
adducts in C57BL/6 mouse skin in vivo. A dose-dependent increase in bo
th the level of BPDE-DNA adducts and nuclear p53 immunoreactivity was
found in mice treated topically with 50-750 mu g benzo[a]pyrene. Such
a positive correlation between the adducts and p53 positivity was sugg
ested by an earlier study. Since p53 probably functions in DNA damage
control, interference by TPA with the p53 response could be a mechanis
m in TPA-induced tumor promotion. Whether such a mechanism is more gen
eral in tumor promotion deserves further study.